Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 30.07 % |
3 Month Return | + 33.08 % |
1 Year Return | + 39.8 % |
Market Stats | |
Previous Close | ₹109.74 |
Open | ₹111.90 |
Volume | 27.50K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹236.61Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹236.61 Cr |
P/B Ratio | -1.1 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹236.61 Cr | 3.5% | 0.96 | NA | NA | |
NA | ₹370.18 Cr | 56.39% | 0.74 | NA | NA | |
BUY | ₹16,014.81 Cr | 488.49% | 0.51 | ₹314 Cr | ₹2,177 Cr | |
NA | ₹767.60 Cr | 47.02% | 0.52 | NA | NA | |
NA | ₹227.12 Cr | 240.73% | 0.58 | -₹12 Cr | ₹15 Cr |
Organisation | Krebs Biochemicals & Industries Ltd |
Headquarters | Hyderabad |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Krebs Biochemicals & Industries Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 64.7% return, outperforming this stock by 24.9%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 72.74% of holdings in Sep 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 140.6% return, outperforming this stock by 175.9%
FII Holding Unchanged
Foreign Institutions holdings remained unchanged at 0.49% of holdings in Sep 2024 quarter
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 26.76% of holdings in Sep 2024 quarter
Price Dip
In the last 7 days, KREBSBIO stock has moved down by -6.5%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 72.74% | 0.00 | |
Foreign Institutions | 0.49% | ||
Mutual Funds | 0% | 0.00 | |
Retail Investors | 26.76% | 0.00 | |
Others | 0.01% | 250.00 |
Krebs Biochemicals & Industries Ltd’s net profit fell -61.34% since last year same period to ₹-5.76Cr in the Q2 2024-2025. On a quarterly growth basis, Krebs Biochemicals & Industries Ltd has generated -11.41% fall in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Krebs Biochemicals & Industries Ltd is currently in a Bullish trading position according to technical analysis indicators.
Krebs Biochemicals & Industries Ltd (KREBSBIO) share price today is ₹106.58
Krebs Biochemicals & Industries Ltd is listed on NSE
Krebs Biochemicals & Industries Ltd is listed on BSE
Today’s traded volume of Krebs Biochemicals & Industries Ltd(KREBSBIO) is 27.50K.
Today’s market capitalisation of Krebs Biochemicals & Industries Ltd(KREBSBIO) is ₹236.61Cr.
Krebs Biochemicals & Industries Ltd(KREBSBIO | Price |
---|---|
52 Week High | ₹129.07 |
52 Week Low | ₹60.35 |
Krebs Biochemicals & Industries Ltd(KREBSBIO) share price is ₹106.58. It is down -17.42% from its 52 Week High price of ₹129.07
Krebs Biochemicals & Industries Ltd(KREBSBIO) share price is ₹106.58. It is up 76.60% from its 52 Week Low price of ₹60.35
Krebs Biochemicals & Industries Ltd(KREBSBIO | Returns |
---|---|
1 Day Returns | -3.16% |
1 Month Returns | 30.07% |
3 Month Returns | 33.08% |
1 Year Returns | 39.8% |